<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Rut-<z:chebi fb="0" ids="30351">bpy</z:chebi> is a novel <z:chebi fb="1" ids="16480">nitrosyl</z:chebi>-<z:chebi fb="6" ids="30682">ruthenium</z:chebi> complex releasing NO into the vascular system </plain></SENT>
<SENT sid="1" pm="."><plain>We evaluated the effect of Rut-<z:chebi fb="0" ids="30351">bpy</z:chebi> (100 mg/kg) on a rat model of brain <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Forty rats were assigned to four groups (Saline solution [SS], Rut-<z:chebi fb="0" ids="30351">bpy</z:chebi>, SS+<z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-reperfusion [SS+I/R] and Rut-<z:chebi fb="0" ids="30351">bpy</z:chebi>+<z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-reperfusion [Rut-<z:chebi fb="0" ids="30351">bpy</z:chebi>+I/R]) with their mean arterial pressure (MAP) continuously monitored </plain></SENT>
<SENT sid="3" pm="."><plain>The groups were submitted (SS+I/R and Rut-<z:chebi fb="0" ids="30351">bpy</z:chebi>+I/R) or not (SS and Rut-<z:chebi fb="0" ids="30351">bpy</z:chebi>) to incomplete global <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e> by occlusion of the common bilateral carotid arteries during 30 min followed by reperfusion for further 60 min </plain></SENT>
<SENT sid="4" pm="."><plain>Thirty minutes before <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, rats were treated pairwise by intraperitoneal injection of saline solution or Rut-<z:chebi fb="0" ids="30351">bpy</z:chebi> </plain></SENT>
<SENT sid="5" pm="."><plain>At the end of experiments, brain was removed for triphenyltetrazolium <z:chebi fb="76" ids="17996">chloride</z:chebi> staining in order to quantify the total ischemic area </plain></SENT>
<SENT sid="6" pm="."><plain>In a subset of rats, hippocampus was obtained for histopathology scoring, nitrate and <z:chebi fb="95" ids="16301">nitrite</z:chebi> measurements, immunostaining and western blotting of the nuclear factor- κB (NF-κB) </plain></SENT>
<SENT sid="7" pm="."><plain>Rut-<z:chebi fb="0" ids="30351">bpy</z:chebi> pre-treatment <z:mp ids='MP_0004876'>decreased MAP</z:mp> variations during the transition from <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e> to reperfusion and decreased the fractional injury area </plain></SENT>
<SENT sid="8" pm="."><plain>Rut-<z:chebi fb="0" ids="30351">bpy</z:chebi> pre-treatment reduced NF-κB hippocampal immunostaining and protein expression with improved histopathology scoring as compared to the untreated operated control </plain></SENT>
<SENT sid="9" pm="."><plain>In conclusion, Rut-<z:chebi fb="0" ids="30351">bpy</z:chebi> improved the total <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> area and hippocampal neuronal viability in part by inhibiting NF-κB signaling and helped to stabilize the blood pressure during the transition from <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> to reperfusion </plain></SENT>
</text></document>